Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine added to prephase and consolidation therapy in adult acute lymphoblastic leukemia
2008-005798-36Phase 2Completed
- Sponsor
- HOVON
- Start
- Feb 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of clofarabine in acute lymphoblastic leukemia (ALL) and T-lymphoblastic lymphoma (T-LBL) (2 arms), sponsored by HOVON. Primary endpoint: Feasibility of adding clofarabine (Phase II). Started Feb 2009; status: completed.
02
Drugs
clofarabine
03
Conditions
acute lymphoblastic leukemia (ALL)T-lymphoblastic lymphoma (T-LBL)
Beyond the preview
Go deeper on 2008-005798-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005798-36.